1Kong WJ,Chen JJ,Zheng ZY,et al.Prevalence of allergic rhinitis in 3-6- year-old children in Wuhan of China[J].Clin Exp Allergy,2009,39:869- 874.
2Bousquet J,Van Cauwenberge P,Khaltaev N,et al.Allergic rhinitis and its impact on asthm[J].J Allergy Clin Immunol,2001,108:147-334.
3Moiler C,Ahlstroom H,Henricson KA,et al.Safety of nasal budesonide in the long-term treatment of children with perennial rhinitis[J].Clin Exp Allergy,2003,33:816-822.
4Canonica GW,Tarantini F,Compalati E,et al.Efficacy of desloratadine in the treatment of allergic rhinitis:a meta-analysis of randomized,double- blind,controlled trials[J].AUergy,2007,62:359-366.
5Moiler C,Ahlstroom H,Henricson KA,et al.Safety of nasal budesonide in the long-term treatment of children with perennial rhinltis [J].Clin Exp Allergy,2003,33:816-822.
6Noon L.Prophylactic inoculation against hay fever [J].Lancet,1911,1: 1572-1573.
7Jaclbsen L,Niggemann B,Dreborg,et al.Specific immunotherapy has ong- ternm preventive effect of seasonal and perennial asthma:-year follow- up on the PAT study[J].Allergy,2007,62:943-948.
8Cox L, Larenas-Linnemann D,Lockey RF,et al.Speaking the same lan- guage:The World Allergy Organization Subcutaneous immunotherapy systemic reaction grading system[J].J Allergy Clin Immunol,2010,125(3): 569-574.
9Scadding Gk,Brostoff J.Low dose sublingual therapy in patients with al- lergic rhinitis due to house dust mite [J].Clinical AUergy,1986,16 (5): 483-491.
10Penagos M,Compalati E,Tarantini F,et al.Efficacy of sublingual im- munotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age[J].Ann Allergy Asthma Immunol,2006,97:141-148.
